QSC RESEARCH GRADE
≥99% HPLC PurityMS ConfirmedJanoshik COAIn-House SPPS1-Region Domestic Shipping
What is Finasteride?
Finasteride 1mg is a low-dose formulation of the competitive 5α-reductase Type II inhibitor — the clinically established dose for androgenetic alopecia research models. At 1mg, scalp and serum DHT are reduced ~60–70%, with minimal impact on total testosterone. Enables hair follicle DHT research, dermal papilla AR sensitivity studies, and dose-comparative 5α-reductase inhibition protocols. Research use only.
Research Applications
Hair Follicle DHT Research
Scalp DHT reduction, dermal papilla AR sensitivity, follicle miniaturisation models
Androgenetic Alopecia
Hair cycle modulation, telogen:anagen ratio, miniaturisation reversal studies
Low-Dose 5α-Reductase Inhibition
1mg vs 5mg dose comparison — scalp vs systemic DHT reduction profiles
Dermal Papilla Biology
DHT-mediated papilla cell apoptosis, AR expression, growth factor signalling
HPG Axis at Low Dose
Minimal T→DHT impact on feedback — LH/FSH response at 1mg finasteride
Quick Specs
| Form | Tablet — 1mg per tablet, 100-tablet bottle |
| CAS Number | 98319-26-7 |
| Molecular Formula | C₂₃H₃₆N₂O₂ |
| Molecular Weight | 372.5 g/mol |
| Compound Type | 5α-Reductase Type II Inhibitor |
| Purity | ≥99% by HPLC — every batch |
| Identity | MS molecular weight confirmed — every batch |
| COA | Janoshik-independent, publicly verifiable |
| Manufacture | In-house synthesis — Qingdao, China |
| Storage | Room temperature sealed | cool, dry storage |
| Shelf Life | 24 months unopened |

